I feel the benefits for overall health make it a risk for the average person to take, he continued
20% higher D30 engagement from new features launched September 22, 2025 is based on a pre-post analysis from August 22 to October 24, 2025 of D30 engagement in key in-app behaviours (completing any Home Screen Task, tapping the Bank button to bank rewards for steps, viewing the Health Report, logging medication, or reading an article)
Starting at $139/mo Microdosing GLP-1 is designed to work in sync with your body, which may minimize side effects and support moderate weight loss
As a result, compared with other hypoglycemic drugs, GLP-1RAs has a lower risk of hypoglycemia
Many plan sponsors now restrict GLP1 eligibility to clear clinical criteria such as FDAapproved uses for Type 2 diabetes or obesity above specific BMI thresholds with standardized medical documentation required
We focus on "smart dosing"using high-quality, bioavailable formats that provide the body with exactly what it needs without overloading the system